New Study Reveals Role of Kaposi Sarcoma-Associated Herpesvirus Protein K5 in Preventing Cell Death

Strategic Insights -

Research conducted at the National Cancer Institute has shed new light on the role of Kaposi sarcoma-associated herpesvirus (KSHV) protein K5 in preventing cell death during lytic replication. The study, published in the Journal of Virology, found that K5 is a substrate for caspases and plays a crucial role in preventing caspase-mediated cell death. This discovery has important implications for understanding the mechanisms by which KSHV evades host defense responses.

Key Takeaways:

  • The study identified K5 as a substrate for caspases and demonstrated its role in preventing caspase-mediated cell death during lytic replication.
  • K5 was found to be cleaved by caspases at a specific site, and this cleavage did not affect its ability to downregulate immune surface markers.
  • The study suggests that K5 plays an additional role in mitigating caspase-mediated cell death during lytic replication, making it a critical factor in the survival of KSHV-infected cells.
  • KSHV is the etiological agent for Kaposi sarcoma, primary effusion lymphoma, multicentric Castleman's disease, and KSHV inflammatory cytokine syndrome.
  • Understanding how KSHV thwarts host defense responses is essential for developing strategies to treat these rare and deadly diseases.
  • The research has been peer-reviewed and published in the Journal of Virology.

Statistics:

  • 25% decrease in viability of K5-knockout cells compared to wild-type-infected cells during lytic replication.
  • K5 was found to be cleaved by caspases at a specific site (D222).
  • 100% of K5-FLAG-expressing cells showed caspase processing of K5 when treated with Fas.

Sources:

  • Caspase cleavage of Kaposi sarcoma-associated herpesvirus proteins: a role for K5 in preventing caspase-mediated cell death during lytic replication. Journal of Virology, 2025.
  • Amer Soc Microbiology, 1752 N St NW, Washington, DC 20036-2904, USA.
  • National Cancer Institute (NCI), Bethesda, Maryland, United States.